Gum to replace needles?

February 2006
Pharmaceutical Technology Europe;Feb2006, Vol. 18 Issue 2, p10
Trade Publication
The article reports on Generex's development of a chewing gum as an alternative buccal drug delivery method for metformin, which is used for treating diabetes. Results from a small clinical trial suggest that the use of chewing gum could prevent gastrointestinal side-effects which usually accompany the use of metformin tablets


Related Articles

  • PREPARATION AND CHARACTERIZATION OF METFORMIN PRONIOSOMAL GEL FOR TREATMENT OF DIABETES MELLITUS. Loona, Sandeep; Gupta, Nitan Bharti; Khan, M. U. // International Journal of Pharmaceutical Sciences Review & Resear;Jul/Aug2012, Vol. 15 Issue 2, p108 

    The aim of the investigation was to design a proniosomal carrier system of metformin hydrochloride for the treatment of type - 2 diabetes mellitus that is capable of delivering entrapped drug over an extended period of time. Proniosomes of metformin hydrochloride were prepared by coacervation...

  • Design, development and evaluation of hollow microspheres of Repaglinide. Ahmed, Abdul Baquee; Sengupta, Rupa; Deb, Ratul // Journal of Chemical & Pharmaceutical Research;2014, Vol. 6 Issue 9, p267 

    The objective of the study was to prepare hollow microsphere as a new dosage form of floating drug delivery system with prolonged stomach retention time. Hollow microspheres containing Repaglinide were prepared by emulsion diffusion method using Eudragit S100 and Eudragit L100 as release...

  • GENEREX AWARDED TWO NEW PATENTS FOR BUCCAL DRUG DELIVERY.  // Biotech Business;Jul2010, Vol. 23 Issue 7, p7 

    The article reports that Generex Biotechnology Corporation was awarded patents in Japan and Ukraine. According to Rose C. Perri, the company's chief operating officer, each patent issuance suggests the inventiveness of the company's buccal drug delivery platform technologies. Generex is based in...

  • Generex Biotechnology: vaccines a clear way ahead for RapidMist.  // PharmaWatch: Biotechnology;September 2004, Vol. 3 Issue 9, p6 

    Reports on the innovation made by Generex Biotechnology Corp. for the RapidMist platform technology for vaccine delivery. Uncertain profitability of the delivery system; Discussion of the prospects for Generex's RapidMist delivery system during the Foundation Merieux Conference in 2004.

  • New drugs and dosage forms.  // American Journal of Health-System Pharmacy;4/15/2010, Vol. 67 Issue 8, p588 

    The article reviews information on several new drugs and drug dosage forms including extended release tablets of Hydromorphone hydrochloride, injectable suspension of Triprotein pamoate, and Velaglucerase alfa for injection.

  • ALPHABETICAL INDEX.  // Monthly Prescribing Reference;Oct2016, Vol. 32 Issue 10, p276 

    An alphabetical index of several medications for used in treating different diseases and ailments is presented.

  • GENEREX BIOTECHNOLOGY AWARDED NEW DRUG DELIVERY PATENT.  // Worldwide Biotech;Dec2008, Vol. 20 Issue 12, p1 

    The article reports on a drug delivery patent received by Generex Biotechnology Corp., a leading provider of drug delivery for metabolic diseases through the inner lining of the mouth, in Australia. A patent titled Micellar Pharmaceutical Compositions for Buccal and Pulmonary Application has...

  • Generex Biotechnology: vaccines a clear way ahead for RapidMist.  // PharmaWatch: Monthly Review;September 2004, Vol. 3 Issue 9, p50 

    Reports on chief scientific officer of Generex Biotechnology's Antigen Express immunomedicines subsidiary, Robert Humphreys' presentation of a research abstract at the Foundation Merieux Conference discussing the prospects for the company's RapidMist delivery system. Benefits of the technology...

  • Insulin spray will eliminate needles.  // Hudson Valley Business Journal;09/25/2000-10/09/2000, Vol. 11 Issue 16, p14 

    Reports that Eli Lilly and Co. has signed an agreement with Generex Biotechnology Corp. to develop insulin that is administered as a fine spray into the mouth.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics